The FDA’s proposed Foundation Model Device Master Files would allow AI developers to share confidential architecture data directly with regulators to ensure safety. This paradigm shift addresses the reality that modern medical devices are no longer static tools but are instead interconnected nodes
The decision by Blue Cross Blue Shield of Michigan to end 'incident-to' billing threatens to disrupt the therapeutic relationships of thousands of patients currently in treatment. This sudden administrative shift has sent shockwaves through the local healthcare landscape, forcing clinicians and
The landscape of breast cancer therapy is shifting away from the rigid confines of the infusion chair and toward the sanctuary of the home, as medical systems look to prioritize patient autonomy. Research recently published in JAMA Network Open suggests that virtual oversight allows medical teams
This diagnostic breakthrough represents a move away from reactive symptom management toward a proactive clinical approach centered on early biological detection. The official clearance by the U.S. Food and Drug Administration of the PrecivityAD2 blood test establishes a sophisticated benchmark for
Beyond direct expense reimbursement, the $3 million fund will provide a pro rata cash distribution to every eligible claimant who submits a valid claim by the deadline. This resolution follows the intense legal scrutiny of Healthcare Services Group, a major provider of support services to nursing
Financial stability in the wake of a hack depends largely on an organization's ability to absorb sudden, high costs without affecting debt service. In the current economic landscape, credit rating agencies have elevated cybersecurity from a technical footnote to a primary pillar of institutional
